FDA Calls Psychedelic Psilocybin a ‘Breakthrough Therapy’ for Severe Depression | Live Science

The FDA is helping to speed up the process of developing and approving a drug based on psilocybin, a hallucinogenic substance in magic mushrooms, to treat depression.

Source: FDA Calls Psychedelic Psilocybin a ‘Breakthrough Therapy’ for Severe Depression | Live Science